Integrated proteomic and targeted Next Generation Sequencing reveal relevant heterogeneity in lower-grade meningioma and ANXA3 as a new target in NF2 mutated meningiomas. - Shah M; Akther Y; Adams CL; Banton MC; Sharma V; Ercolano E; Hilton DA; Kurian KM; Laraba L; Woznica W; Parkinson DB; de Assis LJ; et al. (EBioMedicine, 2025)